| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 16, 2023 | AMRN Amarin Corp Plc\uk | Holt Patrick | President And CEO | Buy | 300,000 | $1.04 | $312,315.21 | +31.8% | -29.1% | -41.6% | |
| Aug 16, 2023 | ANIP Ani Pharmaceuticals Inc | Meridian Venture Partners II LP | 10% Owner | Sell | 200,000 | $58.50 | $11,700,000.00 | -9.9% | -10.4% | +2.9% | |
| Aug 16, 2023 | CBSTF Cannabist Co Holdings Inc. | Olson Bryan | Chief People/ Admin Officer | Sell | 91,814 | $0.42 | $38,602.33 | -4.9% | - | - | |
| Aug 16, 2023 | EOLS Evolus, Inc. | Moatazedi David68 | See Remarks | Sell | 14,778 | $10.27 | $151,770.06 | -2.1% | -17.2% | +33.3% | |
| Aug 16, 2023 | EOLS Evolus, Inc. | Avelar Rui67 | See Remarks | Sell | 2,211 | $10.27 | $22,706.97 | -0.6% | -17.2% | +33.3% | |
| Aug 16, 2023 | EOLS Evolus, Inc. | Beaver Sandra67 | Chief Financial Officer | Sell | 2,211 | $10.27 | $22,706.97 | -1.9% | -17.2% | +33.3% | |
| Aug 15, 2023 | LNTH Lantheus Holdings, Inc. | Marshall Robert J. Jr.53 | CFO And Treasurer | Sell | 10,000 | $68.52 | $685,200.00 | -8.5% | -5.7% | +38.7% | |
| Aug 15, 2023 | AMLX Amylyx Pharmaceuticals, Inc. | Mazzariello Gina53 | Chief Legal Officer | Sell | 6,164 | $20.88 | $128,686.44 | -11.2% | -38.4% | -89.9% | |
| Aug 15, 2023 | AMPH Amphastar Pharmaceuticals, Inc. | Zasloff Michael A53 | Director | Sell | 12,759 | $57.22 | $730,025.32 | -27.4% | -6.5% | -25.9% | |
| Aug 15, 2023 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 50,222 | $543.72 | $27,306,747.21 | - | +12.1% | +70.4% | |
| Aug 15, 2023 | AMPH Amphastar Pharmaceuticals, Inc. | Prins Richard K61 | Director | Sell | 4,163 | $57.39 | $238,911.24 | -8.8% | -6.5% | -25.9% | |
| Aug 15, 2023 | ANIP Ani Pharmaceuticals Inc | Shanmugam Muthusamy59 | Head Of R&D, Coo-novitium Ops | Sell | 50,000 | $61.35 | $3,067,449.50 | -2.1% | -16.5% | -4.3% | |
| Aug 15, 2023 | EOLS Evolus, Inc. | Malik Vikram54 | Director | Buy | 174,967 | $7.41 | $1,296,505.47 | +174.0% | -20.4% | +34.7% | |
| Aug 15, 2023 | ANIP Ani Pharmaceuticals Inc | Lalwani Nikhil66 | President &CEO | Sell | 68,282 | $58.32 | $3,982,547.58 | -8.8% | -16.5% | -4.3% | |
| Aug 14, 2023 | IRWD Ironwood Pharmaceuticals Inc | John Minardo69 | Chief Legal Officer | Sell | 7,045 | $10.04 | $70,731.80 | -3.5% | -6.3% | -55.2% | |
| Aug 14, 2023 | IRWD Ironwood Pharmaceuticals Inc | Silver Ronald68 | Principal Accounting Officer | Sell | 1,976 | $10.04 | $19,839.04 | -1.5% | -6.3% | -55.2% | |
| Aug 14, 2023 | ANIP Ani Pharmaceuticals Inc | Carey Stephen P.55 | SVP &CFO | Sell | 17,639 | $61.37 | $1,082,505.43 | -10.2% | -15.5% | -3.5% | |
| Aug 14, 2023 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 164,778 | $539.08 | $88,829,242.94 | - | +13.9% | +68.8% | |
| Aug 14, 2023 | MRK Merck & Co., Inc. | Mizell Steven52 | EVP, Chief Hr Officer | Sell | 4,250 | $109.01 | $463,292.50 | -15.6% | -5.3% | +7.8% | |
| Aug 14, 2023 | HROW Harrow, Inc. | Makary Martin A. | Director | Buy | 20,000 | $16.92 | $338,400.00 | +80.0% | -25.8% | +119.0% | |
| Aug 14, 2023 | ANIP Ani Pharmaceuticals Inc | Pera Antonio R58 | Director | Sell | 3,000 | $60.37 | $181,110.00 | -8.2% | -15.5% | -3.5% | |
| Aug 14, 2023 | HROW Harrow, Inc. | Baum Mark L66 | Chief Executive Officer | Buy | 5,800 | $17.05 | $98,890.00 | +0.3% | -25.8% | +119.0% | |
| Aug 14, 2023 | AVDL Avadel Pharmaceuticals Plc | McHugh Thomas S73 | Chief Financial Officer | Buy | 2,000 | $14.45 | $28,900.00 | +2.6% | -23.0% | +16.4% | |
| Aug 14, 2023 | HIMS Hims & Hers Health, Inc. | O'Keefe Lynne Chou | Director | Sell | 45,748 | $7.15 | $327,098.20 | -100% | -1.7% | +124.4% | |
| Aug 14, 2023 | ASRT Assertio Holdings, Inc. | McKee William | Director | Sell | 22,000 | $3.14 | $69,044.80 | -8.4% | -67.2% | -65.0% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.